User profiles for Mang M. Ma
Mang MaOther name: Mang M. Ma Professor of Medicine, University of Alberta Verified email at ualberta.ca Cited by 7477 |
[PDF][PDF] Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value
As detected by cross‐sectional imaging, severe muscle depletion, which is termed sarcopenia,
holds promise for prognostication in patients with cirrhosis. Our aims were to describe the …
holds promise for prognostication in patients with cirrhosis. Our aims were to describe the …
Mutation in Hbv Rna–Dependent Dna Polymerase Confers Resistance to LamivudineIn Vivo
GA Tipples, MM Ma, KP Fischer, VG Bain… - Hepatology, 1996 - journals.lww.com
The (–) enantiomer of 3′–thiacytidine (lamivudine) has been found to be a potent inhibitor
of hepatitis B virus (HBV) and human immunodeficiency virus (HIV) replication. Mutation of …
of hepatitis B virus (HBV) and human immunodeficiency virus (HIV) replication. Mutation of …
[PDF][PDF] Sirolimus‐based immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinoma
…, M Al Saghier, GA Meeberg, M Blitz, MM Ma… - Liver …, 2004 - Wiley Online Library
An increasing number of patients with hepatocellular carcinoma (HCC) are undergoing
evaluation for listing for liver transplantation. Criteria for selection require ongoing review for …
evaluation for listing for liver transplantation. Criteria for selection require ongoing review for …
Noninvasive diagnosis of portal hypertension in patients with compensated advanced chronic liver disease
METHODS: This is an international cohort study including patients with paired LSM/hepatic
venous pressure gradient (HVPG), LSM≥ 10 kPa, and no previous decompensation. Portal …
venous pressure gradient (HVPG), LSM≥ 10 kPa, and no previous decompensation. Portal …
De novo sirolimus-based immunosuppression after liver transplantation for hepatocellular carcinoma: long-term outcomes and side effects
…, J Oberholzer, AMJ Shapiro, K Gutfreund, MM Ma… - …, 2007 - journals.lww.com
Background. We report long-term outcomes and side effects after transplantation for hepatocellular
carcinoma (HCC) using de novo, sirolimus-based immunosuppression (IS). Methods. …
carcinoma (HCC) using de novo, sirolimus-based immunosuppression (IS). Methods. …
Transplant immunosuppressive agents in non‐transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with …
N Chatur, A Ramji, VG Bain, MM Ma… - Liver …, 2005 - Wiley Online Library
Background: Conventional treatment of autoimmune hepatitis consists of either prednisone
alone or in combination with azathioprine. Ten to 20% of patients do not respond to or are …
alone or in combination with azathioprine. Ten to 20% of patients do not respond to or are …
Management of chronic hepatitis B: Canadian Association for the Study of the Liver consensus guidelines
Chronic hepatitis B (CHB) is a dynamic disease that is influenced by host and virological
factors. The management of CHB has become more complex with the increasing use of long-…
factors. The management of CHB has become more complex with the increasing use of long-…
A shorter duration of pre-transplant abstinence predicts problem drinking after liver transplantation
OBJECTIVES: Liver transplantation for alcoholic liver disease (ALD) can be complicated by
abusive or “problem” drinking (PD) after transplant. There are limited data for evaluating the …
abusive or “problem” drinking (PD) after transplant. There are limited data for evaluating the …
[PDF][PDF] Impact of implementing a “FIB‐4 first” strategy on a pathway for patients with NAFLD referred from primary care
Detection of advanced fibrosis in nonalcoholic fatty liver disease (NAFLD) is essential for
stratifying patients according to the risk of liver‐related morbidity. Noninvasive methods such as …
stratifying patients according to the risk of liver‐related morbidity. Noninvasive methods such as …
Management of hepatitis B virus infection: 2018 guidelines from the Canadian Association for the Study of Liver Disease and Association of Medical Microbiology and …
…, C Fournier, E Kelly, HH Ko, MM Ma… - Canadian Liver …, 2018 - canlivj.utpjournals.press
Hepatitis B virus (HBV) infection is an important public health problem in Canada. In keeping
with evolving evidence and understanding of HBV pathogenesis, the Canadian Association …
with evolving evidence and understanding of HBV pathogenesis, the Canadian Association …